EpiPGX project video – review and forecast after 4 years of ambitious epilepsy research
What is the innovation capacity of EpiPGX project? And what makes this EU- funded epilepsy project so valuable? After four years of scientific research, the consortium presents its latest findings on epilepsy pharmacogenomics. The project gives hope to about 50 million people who suffer from epilepsy worldwide. It’s aim is to individualise and optimise epilepsy treatment with the best outcome for the patients. https://www.youtube.com/watch?v=CwGtrz4XdOc(se abrirá en una nueva ventana)
Palabras clave
Países
Belgium, Germany, Finland, Ireland, Iceland, Italy, Luxembourg, Netherlands, United Kingdom